Compare · RBOT vs STE
RBOT vs STE
Side-by-side comparison of Vicarious Surgical Inc. (RBOT) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RBOT and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $21.27B, about 29.8x RBOT ($714.1M).
- Over the past year, RBOT is down 77.0% and STE is down 2.3% - STE leads by 74.7 points.
- RBOT has been more active in the news (4 items in the past 4 weeks vs 3 for STE).
- STE has more recent analyst coverage (16 ratings vs 6 for RBOT).
- Company
- Vicarious Surgical Inc.
- STERIS plc (Ireland)
- Price
- $1.99-0.75%
- $216.86+1.94%
- Market cap
- $714.1M
- $21.27B
- 1M return
- +0.00%
- -1.81%
- 1Y return
- -77.03%
- -2.32%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2020
- News (4w)
- 4
- 3
- Recent ratings
- 6
- 16
Vicarious Surgical Inc.
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest RBOT
- SEC Form 10-Q filed by Vicarious Surgical Inc.
- Vicarious Surgical Reports First Quarter 2026 Financial Results
- Vicarious Surgical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Amendment: SEC Form SCHEDULE 13D/A filed by Vicarious Surgical Inc.
- Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
- Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
- SEC Form DEF 14A filed by Vicarious Surgical Inc.
- SEC Form 25-NSE filed by Vicarious Surgical Inc.
- SEC Form PRE 14A filed by Vicarious Surgical Inc.
- Vicarious Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Latest STE
- STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
- Teleflex Announces Governance Updates
- SEC Form 8-K filed by STERIS plc (Ireland)
- Amendment: SEC Form SCHEDULE 13G/A filed by STERIS plc (Ireland)
- Director Feldmann Cynthia L exercised 3,098 units of Ordinary Shares at a strike of $152.32 and sold $734,877 worth of Ordinary Shares (3,098 units at $237.21) (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- STERIS Announces Financial Results for Fiscal 2026 Third Quarter
- STERIS Announces Dividend of $0.63 per share